Characterization of a humanized mouse model of Duchenne muscular dystrophy to support the development of genetic medicines. [PDF]
Braunreiter K +11 more
europepmc +1 more source
Selinexor plus ruxolitinib in JAK inhibitor treatment-naïve myelofibrosis: SENTRY Phase 3 study design. [PDF]
Mascarenhas J +10 more
europepmc +1 more source
Effects of 6-month administration of tofogliflozin on cardiac function in elderly patients with heart failure with preserved ejection fraction: A retrospective study of a patient cohort. [PDF]
Higashikawa T +15 more
europepmc +1 more source
Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa. [PDF]
Marinkovich MP +11 more
europepmc +1 more source
Development and preclinical characterization of AMG 329: a human antibody neutralizing FLT3 ligand. [PDF]
Lau-Kilby A +14 more
europepmc +1 more source
Real-World Outcomes Among Patients in the United States Receiving Tafamidis for Transthyretin Amyloid Cardiomyopathy. [PDF]
Judge DP +6 more
europepmc +1 more source
Medinfo 2017 i Hangzhou i Kina
Ekman, Petra, Ahonen, Outi
openaire +2 more sources
Real-time cognitive performance metrics derived from a digital therapeutic for inattention predict ADHD-related clinical outcomes: Replication across three independent trials of AKL-T01. [PDF]
Stamatis CA +4 more
europepmc +1 more source

